Mahkam Zanganeh, Co-CEO: Summit Therapeutics SMMT Buy · Filed 06/12

Trade details

Type: Insider buy
Amount: $49,987,200
Shares · price: 3,810,000 sh · $13.12 a share
Held after: 573,883,879 sh
Stock: Summit Therapeutics SMMT
Person: Mahkam ZanganehCo-CEO
Trade date: 26/06/12
Filed: 26/06/12
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +0.7%

Summit Therapeutics trades, last 26 weeks

What else happened in Summit Therapeutics around then

Filed or reported within 30 days of the trade day · 05/13~07/12

Mahkam Zanganeh's recent trades

Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$1.5M
100,000 sh
$1.5M
Filed 06/04
Traded 06/04
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$500K
26,680 sh
$500K
Filed 25/10/23
Traded 25/10/21
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$5.9M
333,394 sh
$5.9M
Filed 25/09/11
Traded 25/09/10
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$90.4K
5,000 sh
$90.4K
Filed 25/09/11
Traded 25/09/11
Mahkam ZanganehCEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$127.7K
34,321 sh
$127.7K
Filed 24/03/27
Traded 24/03/27